Dragonfly Health and Enclara Pharmacia Join Forces to Usher in a
New Era in the Care-at-Home Space
Dragonfly Health, the leading care-at-home data, technology, and
service platform, has completed its acquisition of Enclara
Pharmacia <https://enclarapharmacia.com/> , a leading pharmacy
solutions provider to form a new, best-in-class solution for
hospice and post-acute care providers. By combining deep clinical
expertise with advanced infrastructure, the combined company will
deliver high-quality, seamless, and efficient care.
Specifically, the unified organization is focused on four areas
of value creation:
* Service: As industry partners, trusted advisers, and
passionate advocates, Enclara and Dragonfly professionals have
built enduring relationships that reflect our shared commitment
to supporting clients and advancing high quality patient care.
Now, we will leverage our unique combination of services,
complementary infrastructure, and expanding reach to create an
even more connected, responsive, and flexible experience for our
partners.
* Technology: E3 Pro(tm) and DMETrack are already
streamlining clinical workflows and reducing administrative
burden for care teams. The breadth of our EMR and EHR integration
capabilities is unmatched, further optimizing workflows and
driving data consistency. Looking ahead, we will build on these
strengths and the ingenuity of our in-house development team to
drive efficiency, stay in front of regulatory requirements, and
best support our clients.
* Data Insights: Together, Dragonfly and Enclara have more
than 30 years of DME and Pharmacy data informing customized,
actionable insights, as well as predictive capabilities. By
unifying these data sources and acting as an extension of client
teams, we will help clients maintain the highest standards of
care while enhancing delivery efficiency, strengthening long-term
operational effectiveness, and supporting fiscally sustainable
growth.
* Clinical Expertise: Dragonfly and Enclara both have
highly skilled clinicians who consistently show up as thought
leaders in our industry and in the daily counsel they provide to
care teams. We are even stronger as a combined team. From
pre-order consultations through delivery, our experts offer
clinically appropriate best practices and consultative support,
engaging early in the care journey to ensure a seamless
experience for everyone involved.
Enclara and Dragonfly are both industry leaders, and we are proud
of the reputation both companies have earned as trusted solutions
providers to hospice, PACE, hospital at home, and skilled nursing
facilities nationwide. As we begin our next phase of integration,
our goal is to bring the best of these two terrific companies
together to even better support our frontline teams and to create
even stronger solutions for our clients, patients, and patient
families.
Note: Although it does not receive the attention as other
stakeholders in the pharmacy market, hospice pharmacy is
experiencing significant growth due to an overall increase in
hospice care demand, driven by factors like an aging population
and greater acceptance of home-based care. Hospice pharmacy is
evolving to offer more seamless medication delivery, often
through specialized pharmacy benefit managers (PBMs) and
technology platforms, as retail and long-term care pharmacies may
not adequately serve hospice patients.
Enclara will become a wholly owned subsidiary of Dragonfly and
allow it to leverage Enclara’s pharmacy capabilities with its
existing DME business to provide customers with a more
streamlined service offering and reduced costs. Dragonfly Health
is the leading care-at-home data, technology, and service
platform and the industry’s first scale DME and pharmacy
solution. The company is furthering the quality of hospice and
post-acute care and increasing operational efficiencies by using
advanced, predictive technology to manage DME and pharmacy
together.
Through a comprehensive network of retail and institutional
pharmacies, a national patient-direct dispensing program and
dedicated inpatient services, Enclara Pharmacia ensures timely
and reliable medication access in any care setting. Combining
clinical expertise, proprietary technology and a patient-focused,
nurse-centric approach, Enclara enables hospices of all sizes and
models to improve quality of life for individuals experiencing
progressive illness.
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
